| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.00072 | 1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |